News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
843,637 Results
Type
Article (86305)
Company Profile (702)
Press Release (756630)
Section
Business (232594)
Career Advice (4125)
Deals (39710)
Drug Delivery (128)
Drug Development (90941)
Employer Resources (198)
FDA (18075)
Job Trends (17318)
News (396277)
Policy (39704)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2993)
Academic (2)
Accelerated approval (5)
Adcomms (29)
Allergies (88)
Alliances (56765)
ALS (93)
Alzheimer's disease (1480)
Antibody-drug conjugate (ADC) (141)
Approvals (18040)
Artificial intelligence (302)
Autoimmune disease (23)
Automation (14)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (21)
Biosimilars (115)
Biotechnology (481)
Bladder cancer (65)
Brain cancer (30)
Breast cancer (276)
Cancer (2183)
Cardiovascular disease (189)
Career advice (3530)
Career pathing (33)
CAR-T (161)
Cell therapy (461)
Cervical cancer (21)
Clinical research (73134)
Collaboration (842)
Compensation (482)
Complete response letters (30)
COVID-19 (2859)
CRISPR (43)
C-suite (232)
Cystic fibrosis (105)
Data (2042)
Decentralized trials (2)
Denatured (43)
Depression (51)
Diabetes (276)
Diagnostics (6889)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (143)
Drug pricing (123)
Drug shortages (33)
Duchenne muscular dystrophy (93)
Earnings (96223)
Editorial (40)
Employer branding (25)
Employer resources (167)
Events (129265)
Executive appointments (692)
FDA (19268)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (755)
Gene editing (111)
Generative AI (33)
Gene therapy (329)
GLP-1 (825)
Government (5121)
Grass and pollen (5)
Guidances (49)
Healthcare (20879)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (131)
Indications (27)
Infectious disease (3009)
Inflammatory bowel disease (148)
Inflation Reduction Act (11)
Influenza (54)
Intellectual property (91)
Interviews (812)
IPO (17794)
IRA (51)
Job creations (5184)
Job search strategy (2861)
Kidney cancer (10)
Labor market (38)
Layoffs (541)
Leadership (21)
Legal (10102)
Liver cancer (76)
Lung cancer (317)
Lymphoma (139)
Machine learning (4)
Management (65)
Manufacturing (311)
MASH (68)
Medical device (14584)
Medtech (14589)
Mergers & acquisitions (22393)
Metabolic disorders (732)
Multiple sclerosis (79)
NASH (23)
Neurodegenerative disease (104)
Neuropsychiatric disorders (31)
Neuroscience (2030)
NextGen: Class of 2025 (7682)
Non-profit (5077)
Northern California (2520)
Now hiring (38)
Obesity (397)
Opinion (270)
Ovarian cancer (75)
Pain (90)
Pancreatic cancer (79)
Parkinson's disease (149)
Partnered (23)
Patents (221)
Patient recruitment (101)
Peanut (51)
People (65084)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22559)
Phase II (31749)
Phase III (23938)
Pipeline (1107)
Podcasts (122)
Policy (141)
Postmarket research (3552)
Preclinical (10133)
Press Release (72)
Prostate cancer (99)
Psychedelics (38)
Radiopharmaceuticals (268)
Rare diseases (407)
Real estate (7386)
Recruiting (75)
Regulatory (26660)
Reports (57)
Research institute (2656)
Resumes & cover letters (649)
Rett syndrome (4)
RNA editing (4)
RSV (47)
Schizophrenia (76)
Series A (133)
Series B (84)
Service/supplier (29)
Sickle cell disease (57)
Southern California (2192)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (33)
Startups (4286)
State (2)
Stomach cancer (16)
Supply chain (67)
Tariffs (14)
The Weekly (77)
United States (22892)
Vaccines (775)
Venture capitalists (39)
Webinars (13)
Weight loss (291)
Women's health (38)
Worklife (19)
Date
Today (75)
Last 7 days (707)
Last 30 days (2768)
Last 365 days (36493)
2025 (9176)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (56)
Alaska (7)
Arizona (261)
Arkansas (14)
Asia (49985)
Australia (8812)
California (5870)
Canada (1923)
China (511)
Colorado (264)
Connecticut (283)
Delaware (139)
Europe (114557)
Florida (854)
Georgia (209)
Hawaii (1)
Idaho (64)
Illinois (592)
India (29)
Indiana (317)
Iowa (10)
Japan (147)
Kansas (108)
Kentucky (27)
Louisiana (12)
Maine (69)
Maryland (908)
Massachusetts (4551)
Michigan (236)
Minnesota (401)
Mississippi (2)
Missouri (87)
Montana (31)
Nebraska (26)
Nevada (58)
New Hampshire (69)
New Jersey (1678)
New Mexico (31)
New York (1675)
North Carolina (1080)
North Dakota (8)
Northern California (2520)
Ohio (207)
Oklahoma (15)
Oregon (47)
Pennsylvania (1304)
Puerto Rico (10)
Rhode Island (30)
South America (1650)
South Carolina (19)
South Dakota (1)
Southern California (2192)
Tennessee (98)
Texas (891)
Utah (175)
Virginia (154)
Washington D.C. (65)
Washington State (566)
West Virginia (3)
Wisconsin (63)
There are 843,637 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Relay Will Cut 70 Employees, Affecting Research Budget by 75%
2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
April 4, 2025
·
167 min read
·
BioSpace Editorial Staff
Layoffs
Spark Therapeutics Cuts 298 Employees as Part of Reorganization
Roche’s reorganization of Spark Therapeutics is coming more into focus, with nearly 300 employees being let go by the end of this year. Spark also trimmed its staff in 2024.
April 4, 2025
·
1 min read
·
Angela Gabriel
Editorial
FDA Gutted Under Trump, RFK Jr., With More Than Half of Senior Leadership Now Gone
While it’s not unusual for certain positions to turn over with a new administration, the number of senior-level FDA staffers who have recently left the agency is unprecedented. The lack of communication, transparency and human decency is as well.
April 4, 2025
·
7 min read
·
Jef Akst
Press Releases
Kiora Pharmaceuticals to Present at The 24th Annual Needham Virtual Healthcare Conference
April 4, 2025
·
1 min read
Press Releases
Telo Genomics Announces Appointment of John Farlinger to Its Board of Directors
April 4, 2025
·
4 min read
Immunology and inflammation
Aldeyra Shares Crash as Dry Eye Drug Gets Second Rejection from FDA
The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.
April 4, 2025
·
2 min read
·
Tristan Manalac
Government
FDA Faces ‘Catastrophic Collapse’ as Massive Layoffs Endanger User Fee Program
The FDA derives just under half of its yearly funding from pharma user fees, which help support its operations and fund employee salaries. An analysis from AgencyIQ suggests that the agency is dangerously close to losing it all.
April 4, 2025
·
3 min read
·
Tristan Manalac
Approvals
Amgen Wins Expansion for Uplizna as First Drug for IgG4-Related Disease
In the Phase III MITIGATE trial, Uplizna cut IgG4-related disease flares by 87% versus placebo.
April 4, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
Lilly Throws Sangamo a Lifeline With Pact Worth Potential $1.4B+
Sangamo, which has been having cash problems, will receive $18 million upfront in licensing fees for its AAV capsid that in preclinical studies has shown the ability to cross the blood-brain barrier.
April 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
BioInvent International AB Publishes Annual Report 2024
April 4, 2025
·
1 min read
1 of 84,364
Next
